MedTrace Logo

Project RESIST: Evaluating the Effects of Anti-smoking Inoculation Messages Among Young Adult Sexual Minority Women

NCT05499520 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2591

Last updated 2024-07-31

Study results available
· View outcomes & findings →

Summary

Project RESIST is an R01 study funded by NCI focused on determining the effects of using culturally tailored inoculation approaches to increase resilience to tobacco marketing influences among young adult sexual minority women ages 18-30 and incorporates critical stakeholder inputs that support later adoption and implementation. The study team is utilizing formative research to design and pre-test anti-smoking messages and two national longitudinal online survey experiments.

Conditions

  • Cigarette Smoking Behavior

Interventions

OTHER

Culturally Tailored Anti-Smoking Messages

Anti-smoking messages will be administered online via a Qualtrics survey.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Harvard School of Public Health (HSPH)

    collaborator OTHER

  • Stanford University

    collaborator OTHER

  • Dana-Farber Cancer Institute

    collaborator OTHER

  • Fenway Community Health

    collaborator OTHER

  • Abramson Cancer Center at Penn Medicine

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-21
Primary Completion
2023-07-05
Completion
2023-08-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05499520 on ClinicalTrials.gov